Payment and coverage issues affecting medical oncology.
Medical oncologists continue to face significant issues in obtaining full payment for and coverage of their services by third-party payers. A number of issues raised by the Medicare fee schedule have, however, been at least partially resolved in a favorable manner. There continue to be problems in coverage of off-label drug uses and services associated with clinical trials. The impending reform of the health care system may improve the situation or it may give rise to further difficulties.
Bailes
J S
JS
D000553:Ambulatory Care; D000970:Antineoplastic Agents / Q000191:economics; D001943:Breast Neoplasms / Q000191:economics; D005245:Fee Schedules; D005260:Female; D006801:Humans; D007349:Insurance, Health, Reimbursement; D008495:Medical Oncology / Q000191:economics* / Q000639:trends; D006278:Medicare; D014481:United States
D000970:Antineoplastic Agents